434 related articles for article (PubMed ID: 25480017)
21. Effect of Schinus terebinthifolius on Candida albicans growth kinetics, cell wall formation and micromorphology.
Alves LA; Freires Ide A; Pereira TM; de Souza A; Lima Ede O; de Castro RD
Acta Odontol Scand; 2013; 71(3-4):965-71. PubMed ID: 23294177
[TBL] [Abstract][Full Text] [Related]
22. In vitro activity of fluconazole on Candida albicans.
Abecia LC; Arévalo JM; López MJ
Microbiologia; 1996 Dec; 12(4):613-20. PubMed ID: 9018696
[TBL] [Abstract][Full Text] [Related]
23. Terpenoids inhibit Candida albicans growth by affecting membrane integrity and arrest of cell cycle.
Zore GB; Thakre AD; Jadhav S; Karuppayil SM
Phytomedicine; 2011 Oct; 18(13):1181-90. PubMed ID: 21596542
[TBL] [Abstract][Full Text] [Related]
24. Insights into the mode of action of anticandidal herbal monoterpenoid geraniol reveal disruption of multiple MDR mechanisms and virulence attributes in Candida albicans.
Singh S; Fatima Z; Hameed S
Arch Microbiol; 2016 Jul; 198(5):459-72. PubMed ID: 26935560
[TBL] [Abstract][Full Text] [Related]
25. [Comparison of broth microdilution and E-test methods for the antifungal susceptibility testing of Candida spp. strains isolated from blood cultures].
Ozcan SK; Mutlu B; Dündar D; Willke A
Mikrobiyol Bul; 2010 Apr; 44(2):263-71. PubMed ID: 20549961
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the in vitro activity of echinocandins against Candida albicans, Candida dubliniensis, and Candida africana by time-kill curves.
Gil-Alonso S; Jauregizar N; Cantón E; Eraso E; Quindós G
Diagn Microbiol Infect Dis; 2015 May; 82(1):57-61. PubMed ID: 25703894
[TBL] [Abstract][Full Text] [Related]
27. Antifungal activity of azole compounds CPA18 and CPA109 against azole-susceptible and -resistant strains of Candida albicans.
Calabrese EC; Castellano S; Santoriello M; Sgherri C; Quartacci MF; Calucci L; Warrilow AG; Lamb DC; Kelly SL; Milite C; Granata I; Sbardella G; Stefancich G; Maresca B; Porta A
J Antimicrob Chemother; 2013 May; 68(5):1111-9. PubMed ID: 23292344
[TBL] [Abstract][Full Text] [Related]
28. Antifungal activity of Coriandrum sativum essential oil, its mode of action against Candida species and potential synergism with amphotericin B.
Silva F; Ferreira S; Duarte A; Mendonça DI; Domingues FC
Phytomedicine; 2011 Dec; 19(1):42-7. PubMed ID: 21788125
[TBL] [Abstract][Full Text] [Related]
29. The inhibitory activity of linalool against the filamentous growth and biofilm formation in Candida albicans.
Hsu CC; Lai WL; Chuang KC; Lee MH; Tsai YC
Med Mycol; 2013 Jul; 51(5):473-82. PubMed ID: 23210679
[TBL] [Abstract][Full Text] [Related]
30. Comparative in vitro fungicidal activity of echinocandins against Candida albicans in peritoneal dialysis fluids.
Tobudic S; Forstner C; Schranz H; Poeppl W; Vychytil A; Burgmann H
Mycoses; 2013 Nov; 56(6):623-30. PubMed ID: 23551835
[TBL] [Abstract][Full Text] [Related]
31. Antifungal activity of 2-chloro-N-phenylacetamide: a new molecule with fungicidal and antibiofilm activity against fluconazole-resistant Candida spp.
Diniz-Neto H; Silva SL; Cordeiro LV; Silva DF; Oliveira RF; Athayde-Filho PF; Oliveira-Filho AA; Guerra FQS; Lima EO
Braz J Biol; 2022; 84():e255080. PubMed ID: 35262564
[TBL] [Abstract][Full Text] [Related]
32. A new in-vitro kinetic model to study the pharmacodynamics of antifungal agents: inhibition of the fungicidal activity of amphotericin B against Candida albicans by voriconazole.
Lignell A; Johansson A; Löwdin E; Cars O; Sjölin J
Clin Microbiol Infect; 2007 Jun; 13(6):613-9. PubMed ID: 17378925
[TBL] [Abstract][Full Text] [Related]
33. Antifungal activity and mode of action of thymol and its synergism with nystatin against Candida species involved with infections in the oral cavity: an in vitro study.
de Castro RD; de Souza TM; Bezerra LM; Ferreira GL; Costa EM; Cavalcanti AL
BMC Complement Altern Med; 2015 Nov; 15():417. PubMed ID: 26601661
[TBL] [Abstract][Full Text] [Related]
34. Candida albicans biofilm inhibition by synergistic action of terpenes and fluconazole.
Pemmaraju SC; Pruthi PA; Prasad R; Pruthi V
Indian J Exp Biol; 2013 Nov; 51(11):1032-7. PubMed ID: 24416942
[TBL] [Abstract][Full Text] [Related]
35. Antifungal activity of cinnamic acid and benzoic acid esters against Candida albicans strains.
Lima TC; Ferreira AR; Silva DF; Lima EO; de Sousa DP
Nat Prod Res; 2018 Mar; 32(5):572-575. PubMed ID: 28423912
[TBL] [Abstract][Full Text] [Related]
36. Antifungal mechanism of an antimicrobial peptide, HP (2--20), derived from N-terminus of Helicobacter pylori ribosomal protein L1 against Candida albicans.
Lee DG; Park Y; Kim HN; Kim HK; Kim PI; Choi BH; Hahm KS
Biochem Biophys Res Commun; 2002 Mar; 291(4):1006-13. PubMed ID: 11866466
[TBL] [Abstract][Full Text] [Related]
37. [In vitro biofilm formation and relationship with antifungal resistance of Candida spp. isolated from vaginal and intrauterine device string samples of women with vaginal complaints].
Calışkan S; Keçeli Özcan S; Cınar S; Corakçı A; Calışkan E
Mikrobiyol Bul; 2011 Oct; 45(4):697-706. PubMed ID: 22090300
[TBL] [Abstract][Full Text] [Related]
38. In vitro antifungal activity of Cinnamomum zeylanicum bark and leaf essential oils against Candida albicans and Candida auris.
Tran HNH; Graham L; Adukwu EC
Appl Microbiol Biotechnol; 2020 Oct; 104(20):8911-8924. PubMed ID: 32880694
[TBL] [Abstract][Full Text] [Related]
39. IN VITRO ANTIFUNGAL ACTIVITY OF 2,4-DIHYDROXY-N-(3-THIOXO-3H- 1,2,4-DITHIAZOL-5-YL)BENZENECARBOTHIOAMIDE.
Lukaszuk C; Krajewska-Kulak E; Niewiadomy A; Szynaka B
Acta Pol Pharm; 2016 Nov; 73(6):1511-1519. PubMed ID: 29634105
[TBL] [Abstract][Full Text] [Related]
40. Multiple effects of green tea catechin on the antifungal activity of antimycotics against Candida albicans.
Hirasawa M; Takada K
J Antimicrob Chemother; 2004 Feb; 53(2):225-9. PubMed ID: 14688042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
